Why So Many Companies Want U.S. Blood

In America, blood means big business. America’s blood makes up 2.69% of U.S. exports, according to the U.S. Census Bureau. Since there is no substitute for human blood, demand can be hard to meet. Over the pandemic, the Red Cross announced its first ever national blood shortage crisis. The shortage prompted the FDA’s 12-month blood donation deferral for men who have sex with men to be shortened to three months time. Advocates want the FDA to follow the science and do away with the ban altogether, following countries like Italy and Spain which have done the same. But outside of the clinic, blood plasma becomes a product.

Grifols, CSL Plasma, Takada’s Biolife and Octapharma are huge players in the plasma collection space and donors are compensated for their donation. Increasingly, plasma donations are becoming an economic coping mechanism for low income communities. Watch the video about to learn more about how the weird economy of blood works, why the U.S. is such a major player and what makes plasma so valuable.

“There are still sporadic shortages,” Dr. Claudia Cohn, chief medical officer of the Association for the Advancement of Blood & Biotherapies, told CNBC.

An early pandemic shortage prompted the FDA to loosen its restriction, which stems from the 1980s AIDS crisis, on accepting blood donations from men who have sex with men. Advocates want the FDA to follow the science and do away with the ban altogether, as have countries such as Italy and Spain.

“There is still government policy that stigmatizes gay and bisexual and other men who have sex with men and carries forward this false notion that there is something inherently diseased about being gay,” Jason Cianciotto, vice president of communications and public policy at Gay Men’s Health Crisis, told CNBC.

A 2014 report found that allowing this community equal access to donating blood could increase the blood supply by 2% to 4% every year.

Grifols, CSL Plasma, Takeda’s Biolife and Octapharma are huge players in the blood collection space, particularly plasma, and donors are compensated.

“Plasma donation [centers] are advertising $900 for your first month giving plasma,” Analidis Ochoa, a doctoral candidate studying social work and sociology at the University of Michigan, told CNBC. “Then it goes down. Usually people can make $30 to $50 each time they go.”

In most countries, blood donation for compensation is banned, but not in the United States. So, the U.S. supplies 70% of the world’s plasma, according to the Niskanen Center.

“What myself and colleagues have worked on is mapping out the location of plasma centers and seeing if there’s a correlation between the address of the center and the poverty level of the area. And what we have found is that they are, in fact, overrepresented in high-poverty areas,” Ochoa said.

She said that plasma donation for compensation is becoming an economic coping mechanism.

“The fact that I got rewarded for donating has kept me donating, because I couldn’t make it otherwise. I couldn’t buy gas. I couldn’t pay my car insurance,” Teresa Clark, a plasma donor, told CNBC. “I can make $650 to $700 a month ... and that helps a lot when you’re on a fixed income.”

» Subscribe to CNBC

» Subscribe to CNBC TV

» Subscribe to CNBC Classic

About CNBC: From 'Wall Street' to 'Main Street' to award winning original documentaries and Reality TV series, CNBC has you covered. Experience special sneak peeks of your favorite shows, exclusive video and more.

Connect with CNBC News Online

Get the latest news

Follow CNBC on LinkedIn

Follow CNBC News on Facebook

Follow CNBC News on Twitter

Follow CNBC News on Instagram

#CNBC

Why So Many Companies Want U.S. Blood